Post-Thrombectomy Alteplase Linked to Better Stroke Recovery

Show Voice Options Emerging research presented at recent stroke conferences indicates that administering the clot-busting drug alteplase directly at the site of arterial blockage after a mechanical thrombectomy procedure may improve recovery outcomes for patients with acute ischemic stroke, with early data showing higher rates of functional independence at 90 days compared with thrombectomy alone; the approach aims to combine the rapid clot removal of thrombectomy with targeted thrombolytic action at remaining microscopic clot fragments, potentially enhancing reperfusion, reducing brain tissue damage and contributing to better neurological recovery without significantly increasing bleeding risk.